Folger Nolan Fleming Douglas Capital Management Inc. Acquires 308 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Folger Nolan Fleming Douglas Capital Management Inc. lifted its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 0.5% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 66,660 shares of the financial services provider’s stock after acquiring an additional 308 shares during the quarter. iShares Biotechnology ETF accounts for about 1.0% of Folger Nolan Fleming Douglas Capital Management Inc.’s holdings, making the stock its 29th biggest holding. Folger Nolan Fleming Douglas Capital Management Inc.’s holdings in iShares Biotechnology ETF were worth $9,706,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the business. Highline Wealth Partners LLC bought a new position in iShares Biotechnology ETF during the 3rd quarter worth approximately $30,000. Bbjs Financial Advisors LLC purchased a new stake in shares of iShares Biotechnology ETF during the second quarter valued at approximately $31,000. Chris Bulman Inc bought a new position in shares of iShares Biotechnology ETF in the second quarter worth approximately $64,000. Eastern Bank bought a new stake in iShares Biotechnology ETF during the 3rd quarter valued at $65,000. Finally, BNP Paribas bought a new stake in iShares Biotechnology ETF during the 1st quarter valued at $69,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of iShares Biotechnology ETF stock opened at $142.41 on Thursday. The company’s fifty day simple moving average is $145.24 and its two-hundred day simple moving average is $140.27. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.